Update on immune checkpoint inhibitors in gynecological cancers
Author:
Affiliation:
1. Department of Hematology-Oncology, National University Hospital, Singapore, Singapore.
2. Cancer Science Institute of Singapore, National University of Singapore, Singapore, Singapore.
Publisher
Asian Society of Gynecologic Oncology; Korean Society of Gynecologic Oncology and Colposcopy
Subject
Obstetrics and Gynecology,Oncology,General Medicine
Link
https://synapse.koreamed.org/pdf/10.3802/jgo.2017.28.e20
Cited by 54 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Prevalence of Mismatch Repair Gene Defects by Means of Immuno-histochemistry Staining for MMR Proteins in Endometrial Cancer;The Journal of Obstetrics and Gynecology of India;2024-08-21
2. Potential role of immune cell therapy in gynecological cancer and future promises: a comprehensive review;Medical Oncology;2024-03-27
3. PD-L1 in a South African cohort of endometrial carcinomas: directions for the future;European Journal of Gynaecological Oncology;2024
4. A Phase II Study of Durvalumab and Tremelimumab in Patients with Advanced Rare Cancer;2024
5. Locally advanced squamous cervical carcinoma (M0): management and emerging therapeutic options in the precision radiotherapy era;Japanese Journal of Radiology;2023-11-21
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3